Published on 6 Nov 2023 on Simply Wall St. via Yahoo Finance
Hikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have...
Key Insights
Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to their trading actions51% of the business is held by the top 10 shareholders Insiders have been selling lately
A look at the shareholders of Hikma Pharmaceuticals PLC (LON:HIK) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 52% ownership. Put another way, the group faces the maximum upside potential (or downside risk).